Literature DB >> 15262346

Efficient prematurity prevention is possible by pH-self measurement and immediate therapy of threatening ascending infection.

U B Hoyme1, E Saling.   

Abstract

In two prospective investigations, the effectiveness of the self care programme for prematurity prevention, developed by Saling, was investigated. Pregnant women in Erfurt have been offered to perform self measurements of their vaginal pH by means of test gloves twice a week in order to screen for any disturbances in the vaginal milieu. The women were instructed to see their physician immediately, if abnormal pH > or = 4.7 or other risk factors were present, in order to get them confirmed and to start lactobacillus acidophilus therapy or in case of bacterial vaginosis to treat with clindamycin cream i. vag. Patients who were not interested in the programme served as a control group. Seventy-three out of 381 women in the intervention group have been identified as risk cases. Fifty-eight of them were treated with a lactobacillus preparation, and 24 with clindamycin cream, three patients refused to have any therapy. In this study, the prematurity rate was 8.1% in the self measurement/intervention group versus 12.3% in the control group (P < 0.05, n = 2341). 0.3% versus 3.3% of the neonates belonged to the group of very early prematures with a gestational age of <32 + 0 (P < 0.01). PROM was registered in 22.8% versus 30.8% (P < 0.001), respectively. Starting 1 March 2000, a similar statewide pH screening programme was initiated in order to reduce prematurity in the State of Thuringia. According to the study design, a significant decrease of prematurity was hypothetically expected for the second half of 2000. In Erfurt, an overall decrease of prematurity from 7.68 to 6.81% and a reduction of cases < or = 32 weeks from 3.22 to 2.39% was observed. Premature rupture of membranes was seen in 19 versus 0 pregnancies with early prematurity (n = 1600). Data from 16,276 women are available for the state of Thuringia. On this basis, a significant reduction of early prematurity from 1.58 to 0.99% was seen, respectively (P < 0.001). Comparing low birthweights a significant reduction of cases was achieved as well in all groups. On the basis of the data obtained we recommend the extension of the campaign in whole of Germany.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15262346     DOI: 10.1016/j.ejogrb.2004.02.038

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  6 in total

1.  Antibiotic Therapy for Premature Rupture of Membranes and Preterm Labor and Effect on Fetal Outcome.

Authors:  B Seelbach-Goebel
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-12       Impact factor: 2.915

2.  Increased vaginal pH in Ugandan women: what does it indicate?

Authors:  G G G Donders; A Gonzaga; C Marconi; F Donders; T Michiels; N Eggermont; G Bellen; J Lule; J Byamughisa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-05-14       Impact factor: 3.267

Review 3.  Use of lactobacilli and estriol combination in the treatment of disturbed vaginal ecosystem: a review.

Authors:  Cihat Unlü; Gilbert Donders
Journal:  J Turk Ger Gynecol Assoc       Date:  2011-12-01

4.  Relationship between lactobacilli and opportunistic bacterial pathogens associated with vaginitis.

Authors:  Mohammad Sabri A Razzak; Alaa H Al-Charrakh; Bara Hamid Al-Greitty
Journal:  N Am J Med Sci       Date:  2011-04

5.  The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women.

Authors:  Roberto Romero; Sonia S Hassan; Pawel Gajer; Adi L Tarca; Douglas W Fadrosh; Lorraine Nikita; Marisa Galuppi; Ronald F Lamont; Piya Chaemsaithong; Jezid Miranda; Tinnakorn Chaiworapongsa; Jacques Ravel
Journal:  Microbiome       Date:  2014-02-03       Impact factor: 14.650

6.  Screening Pregnant Women for Bacterial Vaginosis Using a Point-of-Care Test: A Prospective Validation Study.

Authors:  Philipp Foessleitner; Herbert Kiss; Julia Deinsberger; Julia Ott; Lorenz Zierhut; Klara Rosta; Veronica Falcone; Alex Farr
Journal:  J Clin Med       Date:  2021-05-24       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.